Brief: Concord Healthcare Announces Completion Of China's First Proton Therapy For Choroidal Malignant Melanoma
July 14 (Reuters) - Concord Medical Services Holdings Ltd CCM.N: CONCORD HEALTHCARE ANNOUNCES COMPLETION OF CHINA'S FIRST PROTON THERAPY FOR CHOROIDAL MALIGNANT MELANOMA Source text: ID:nPnPxJcMa Further company coverage: CCM.N
Recent news on Concord Medical Services Holdings
See all newsChina's Concord Medical Services H1 net loss narrows
U.S. STOCKS ON THE MOVE-BILL Holdings, Jackson Financial, Wills Towers Watson
Brief: Concord Healthcare Announces Completion Of China's First Proton Therapy For Choroidal Malignant Melanoma
U.S. STOCKS ON THE MOVE-Oddity Tech, International Paper, Vulcan
U.S. STOCKS ON THE MOVE-Generac, Regulus Therapeutics, Garmin